Clinical trial
Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer…
NCT02162537 · Centre Hospitalier Intercommunal Creteil, Other · Terminated
Key facts
| NCT number | NCT02162537 |
|---|---|
| Title | Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases |
| Official title | Multicentric, Randomized, Phase III Trial Comparing 2 Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Asymptomatic Brain Metastases |
| Acronym | METAL2 |
| Lead sponsor | Centre Hospitalier Intercommunal Creteil, Other |
| Collaborators | Groupe Francais De Pneumo-Cancerologie |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer, Adenocarcinoma of Lung Metastatic to Brain, Cerebral Metastases |
| Intervention type | Drug, Radiation |
| Interventions | Cisplatin, Pemetrexed, Bevacizumab, Cerebral Radiotherapy |
| Enrollment | 95 |
| Start date | Dec 1, 2013 |
| Primary completion | Mar 1, 2018 |
| Completion | Jan 1, 2019 |
| First posted | Jun 12, 2014 |
| Last update posted | Feb 1, 2019 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: